Caribou Biosciences Q3 EPS $(0.30) Beats $(0.36) Estimate, Sales $2.198M Miss $2.650M Estimate

Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.36) by 16.2 percent. This is a 21.05 percent increase over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $2.198 million which missed the analyst consensus estimate of $2.650 million by 17.06 percent. This is a 8.60 percent increase over sales of $2.024 million the same period last year.